NCT01597583

Brief Summary

The main aim of this study is to conduct a randomized control trial to compare MobileMedMinder, a mobile phone based medication reminder software product, with currently accepted and empirically supported methods for increasing medication compliance through reminders and tracking.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 14, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

March 9, 2022

Status Verified

February 1, 2022

Enrollment Period

2.1 years

First QC Date

May 10, 2012

Last Update Submit

February 23, 2022

Conditions

Heart Failure, Congestive

Outcome Measures

Primary Outcomes (1)

  • Compliance

    Pill counts will be used to assess compliance

    3 months

Study Arms (2)

Use of MobileMedMinder

EXPERIMENTAL
Behavioral: Use of MobileMedMinder

Usual care

NO INTERVENTION

Interventions

Use of MobileMedMinderBEHAVIORAL

Use of an intervention to remind patients to take their medications.

Use of MobileMedMinder

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.

You may not qualify if:

  • Inability to understand informed consent
  • Inability to read and understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland

Baltimore, Maryland, 21201, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 10, 2012

First Posted

May 14, 2012

Study Start

November 1, 2011

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

March 9, 2022

Record last verified: 2022-02

Locations

US(1)